Presented by

OVERVIEW
Stocktwits Top 25 Week 16

Source: Tenor

Welcome to the Stocktwits Top 25 Newsletter for Week 16 of 2025!

The Stocktwits Top 25 reports the 25 best-performing stocks in the S&P 500, Nasdaq 100, and Russell 2000 year to date (YTD) and tracks their performances over time. 

Here are the Stocktwits Top 25 Lists for Week 16:

P.S. To help you understand this data further, check out our FAQ page, and feel free to reach out if you have questions!

S&P 500
ST Top 25 S&P 500 💪

The S&P 500 Top 25 list (-0.26%) outperformed the S&P 500 index (-1.50%).

There were 5 major changes to the list this week.

Source: Stocktwits

SPONSORED
200,000+ Stays. 45,000 Rooms. 1 Game-Changing AI. Jurny’s Public Round Closes April 30—Round Almost Full!

The real estate market isn’t just under pressure—it’s breaking. Margins are evaporating. Labor is scarce. And hospitality operators are drowning in legacy tech complexities… all while guests expect instant, five-star service at budget prices.

Jurny is solving that with the industry’s first AI built specifically for hospitality.

Jurny’s next-gen agentic AI, Nia, is eradicating fragmented workflows and automating up to 90% of operational tasks — guest communication across text, voice, and all major booking platforms, high-touch concierge services, automated check-ins and check-outs, AI-powered cleaning coordination, booking management, and much more.

And Jurny’s numbers speak for themselves:

✅ Committed LOIs = 4x current revenue

✅ Powering 200+ management companies worldwide

✅ $16M+ raised from Mucker Capital, Okapi VC, and 2,000+ investors

✅ Global partners: Airbnb, Expedia, Vrbo, Booking.com

The operational burden is over in hospitality. Jurny’s AI just made it profitable – and investable! – again.

Jurny’s round closes on April 30. Don’t miss your chance to invest in the AI that’s transforming hospitality.

*3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here.

NASDAQ 100
The Large-Cap Nasdaq 100 🤖

The Nasdaq 100 Top 25 list (+1.10%) outperformed the Nasdaq 100 index (-2.62%).

There were 2 major changes to the list this week.

Source: Stocktwits

RUSSELL 2000
The Growth-Centric Russell 2000 🦐

The Russell 2000 Top 25 list (+1.91%) outperformed the Russell 2000 index (+1.10%).

There were 5 major changes to the list this week.

Source: Stocktwits

Top Dawg Of The Week 🐶

The Top 25 list’s Top Dawg was Eagle Pharmaceuticals, which rallied 44%. 📈

There was no specific news about the nano-cap biotech company driving this week’s move. Instead, it appears its recent price momentum continued as the small-cap Russell 2000 caught a bid. 🤷 

Source: Stocktwits

$EGRX is up 260% YTD.

Get In Touch 📬

Follow our social channels for great, real-time content on Stocktwits and Twitter. And check out our YouTube channel for in-depth video content! 📲

Help us deliver the best content possible by completing this brief survey. 📝

Email me (Kevin Travers) your feedback; follow me on Stocktwits. I’d love to hear from you. 📧

Want to sponsor this newsletter and reach hundreds of thousands of passionate investors and traders? Reach us here. 👍

Terms & Conditions 📝

Securities Disclaimer: STOCKTWITS IS NOT A TAX ADVISOR, BROKER, FINANCIAL ADVISOR OR INVESTMENT ADVISOR. THE SERVICE IS NOT INTENDED TO PROVIDE TAX, LEGAL, FINANCIAL OR INVESTMENT ADVICE, AND NOTHING ON THE SERVICE SHOULD BE CONSTRUED AS AN OFFER TO SELL, A SOLICITATION OF AN OFFER TO BUY, OR A RECOMMENDATION FOR ANY SECURITY. Trading in such securities can result in immediate and substantial losses of the capital invested. You should only invest risk capital, and not capital required for other purposes. You alone are solely responsible for determining whether any investment, security or strategy, or any other product or service, is appropriate or suitable for you based on your investment objectives and personal and financial situation. You should also consult an attorney or tax professional regarding your specific legal or tax situation. The Content is to be used for informational and entertainment purposes only and the Service does not provide investment advice for any individual. Stocktwits, its affiliates and partners specifically disclaim any and all liability or loss arising out of any action taken in reliance on Content, including but not limited to market value or other loss on the sale or purchase of any company, property, product, service, security, instrument, or any other matter. You understand that an investment in any security is subject to a number of risks, and that discussions of any security published on the Service will not contain a list or description of relevant risk factors. In addition, please note that some of the stocks about which Content is published on the Service have a low market capitalization and/or insufficient public float. Such stocks are subject to more risk than stocks of larger companies, including greater volatility, lower liquidity and less publicly available information. Read the full terms & conditions here. 🔍

Author Disclosure: The author of this newsletter does not hold positions in any of the securities or assets mentioned. 📋